Loading
Latest filing published 28 May 2021 for Genesis Healthcare, Inc., €6,918.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Stephen Scott Young, listed as senior executive, appears in our data through filings on Genesis Healthcare, Inc. shares, published by SEC (Form 4). We count 18 filings; the first trade dates from 3 June 2015 and the latest from 15 May 2021.
The open-market record consists of 11 sales worth €74k, with no purchase. Besides market trades, the filings include 7 share grants.
The newest entry dates from 28 May 2021: a share grant of €6,918, in Genesis Healthcare, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration